1. Introduction
===============

The prevalence of obesity has risen sharply in recent years, reaching epidemic proportions world-wide. According to latest figures from the World Health Organisation approximately 1.6 billion adults are currently overweight (body mass index, BMI ≥25 kg m^−2^), and at least 400 million are clinically obese (BMI ≥30 kg m^−2^). These figures are estimated to reach an alarming 2.3 billion and \>700 million by 2015 ([@bib48]). Obesity is a major risk factor for several chronic conditions including hypertension, cardiovascular disease (CVD), type 2 diabetes, and certain types of cancer and as such poses a major challenge to public health care ([@bib25]). Understanding the biological mechanisms linking obesity and health is therefore of fundamental importance.

Psychological stress is associated with an increased risk of hypertension and CVD and evidence emerging in the past decade suggests that individuals who are more obese may be more responsive to stress. Two of the principle pathways activated by stress are the hypothalamic--pituitary--adrenal axis, leading to elevations in circulating glucocorticoids and the sympathetic nervous system (SNS), resulting in increases in blood pressure, heart rate and circulating catecholamines ([@bib4]). Studies have shown that women with a larger waist circumference or waist--hip ratio have heightened cortisol responses to acute laboratory stress, as well as impaired dexamethasone suppression of cortisol ([@bib14; @bib31]). Similarly, central obesity has been associated with elevated or prolonged cardiovascular responses to acute stress in some but not all studies ([@bib38; @bib19; @bib8; @bib13; @bib43; @bib1]), and a recent report found larger cortisol and cardiovascular responses to public speaking stress in obese versus non-obese women ([@bib2]).

The biological mechanisms linking obesity and stress reactivity are poorly understood. Adipose tissue is now recognised as a major endocrine organ that secretes signalling molecules playing a central role in inflammation, weight regulation and metabolic function including cytokines ([@bib40]). Circulating levels of the hormone-like cytokine leptin are markedly elevated in obese humans and animals and correlate with adiposity measures in non-obese healthy individuals ([@bib10; @bib41]). Leptin is secreted into the blood stream in proportion to adipose tissue mass, and binds to receptors on specific hypothalamic nuclei to regulate energy balance by reducing appetite and stimulating SNS activity ([@bib41]). In rodents, acute systemic or central leptin infusion increases sympathetic nerve activity (SNA) to thermogenic tissues such as brown adipose tissue (BAT) as well as non-thermogenic organs including kidneys and adrenal glands ([@bib33]). Similarly, chronic leptin infusion increases heart rate, arterial blood pressure and circulating catecholamines, and these effects are inhibited by α~1~ and β~1~/β~2~ adrenergic antagonists ([@bib33; @bib12]). The relationship between leptin and SNS activity in humans is less clear. Elevated plasma leptin levels have been reported in patients with hypertension, compared to normotensive individuals ([@bib39]). Similarly, cross-sectional studies have found positive associations between circulating leptin and sympathetic activity indexed by blood pressure, heart rate and heart rate variability in obese and lean normotensive humans ([@bib5; @bib16; @bib26]), and a recent prospective analyses of 489 normotensive men showed that individuals with high serum leptin levels had a 33% increased risk of developing hypertension over 8 years, independent of BMI ([@bib18]). Nevertheless, most intervention studies have found no effect of either acute or chronic leptin infusion on SNS activity in humans ([@bib22; @bib6; @bib27; @bib9]). It is conceivable that the sympatho-activating effects of leptin in humans may be more apparent under conditions of heightened SNS activation induced by factors such as psychological stress.

We set out to investigate the relationship between adiposity, leptin and physiological responses to acute psychological stress in a sample of healthy young women. We predicted that women with greater adiposity would have heightened or prolonged cardiovascular, neuroendocrine and inflammatory responses to stress. We also predicted that leptin would potentiate sympathetic cardiovascular reactivity to stress, so that women with higher basal plasma leptin levels would have larger cardiovascular stress responses.

2. Methods
==========

2.1. Sample
-----------

Sixty-nine female student volunteers were recruited from University College London. Participants were aged between 18 and 25 years, and were screened by structured interview to ensure that they were healthy, not taking any medication and had no previous history of any relevant physical or mental illness. They were instructed not to take antibiotics, ibuprofen or aspirin for 10 days prior to the study and to avoid caffeine, alcohol and excessive exercise during the 12 h prior to testing. On the day of the study, participants were advised to eat a low fat breakfast and were provided with a standardised low fat lunch consisting of vegetable couscous, fruit salad and fresh orange juice. Two participants were excluded from the final analyses since one was extremely obese (BMI 43.3) and another was greatly underweight (BMI 15.6). The study was approved by the joint University College London/University College London Hospital Committee on the Ethics of Human Research and all participants gave their informed consent. We chose to study a healthy population with a wide range of adiposity levels rather than specifically comparing obese versus non-obese individuals, since obese individuals are more likely to have co-morbid conditions such as diabetes or hypertension that may have influenced our measures.

2.2. Anthropometric measures
----------------------------

Anthropometric measures were taken by a research nurse at the beginning of the session. Height was measured to the nearest 0.1 cm using the Frankfort plane to standardise the measurement. Body weight was measured to the nearest 0.1 kg. Body mass index (BMI) was calculated as body weight in kilograms divided by height in metres squared. Waist circumference was measured midway between the lowest rib and ileac crest. Body fat mass was estimated using a Bodystat 1500 bioelectrical impedance body composition analyses device (Bodystat, Douglas, Isle of Man). Fat percentage was calculated as fat weight divided by total (fat + lean) body weight.

2.3. Autonomic and neuroendocrine measures
------------------------------------------

Cardiovascular data for the study were collected continuously and then averaged over specified 5 min trials. Blood pressure was monitored from the finger using a Portapres 2, a portable version of the Finpres device (TNO-TPD Biomedical Instrumentation, Amsterdam, The Netherlands). Heart rate and heart rate variability (HRV) were assessed by impedance cardiography (ICG; VU-AMS, Amsterdam, The Netherlands) as described previously ([@bib46]). HRV was calculated as the root mean square of successive R-R interval differences (RMSSD). A reduction in RMSSD indicates a shift in cardiac sympathovagal balance towards sympathetic control over the rhythm of the heart ([@bib28]). Cardiac pre-ejection period (PEP) was measured as an index of cardiac sympathetic drive ([@bib36]). One minute ensemble averages were derived for the ICG for each minute of tasks and averaged. PEP was defined as the interval between R-wave and B-point plus a fixed Q--R interval of 48 ms. Cortisol was measured in saliva samples obtained throughout the session. Saliva was collected using Salivettes (Sarstedt, Inc. Leicester, UK) and stored at −80 °C prior to analyses. Salivary cortisol was analyzed using a commercially available time-resolved immunoassay with chemiluminescence detection (CLIA; IBL-Hamburg, Hamburg, Germany), at the Technical University of Dresden, Germany. This assay had a detection limit of 0.16 ng/ml and intra-and inter-assay coefficients of variation of \<10 and \<12% respectively.

2.4. Immune measures
--------------------

For assessment of circulating cytokines, blood samples (10 ml) were drawn using a 21-gauge butterfly needle into Vacutainer tubes containing EDTA as an anti-coagulant, then centrifuged immediately at 1250 × *g* for 10 min at room temperature. The plasma layer was removed, aliquoted and stored at −80 °C until analyses. Plasma IL-6 levels were measured using a high-sensitivity two-site enzyme-linked immunosorbent assay (ELISA) from R & D Systems (Oxford, UK). This assay had a detection limit of 0.09 pg/ml with intra- and inter-assay coefficients of variation (CVs) of 5.3 and 9.2% respectively. Plasma IL-1Ra concentrations were measured using a commercial ELISA from R & D Systems, with a detection limit of 15 pg/ml and intra-and inter-assay CVs of \<10%. Plasma leptin levels were assessed using a commercial ELISA from Ray Biotech at Insight Biotechnology Ltd. (Middlesex, UK). This assay had a detection limit of 6 pg/ml and intra-and interassay CVs of \<10% and \<12% respectively. Plasma samples were diluted 1:200 prior to leptin analyses.

2.5. Behavioural tasks
----------------------

Mental stress was induced by two 5-min behavioural tasks, administered under time pressure. The first was a computerized Stroop task, involving the successive presentation of target color words (e.g. red) printed in a different color (e.g. green). The task was to press a computer key that corresponded to the position at the bottom of the screen of the name of the color in which the target word was printed. The second task was presented after an interval of 5 min and involved simulated public speaking. Participants were presented with a hypothetical scenario in which they had been wrongly accused of shoplifting, and were instructed to give a speech in their defense by addressing the camera directly in front of them. They were told that their speech would be video recorded and later judged for efficacy and fluency. The experimenter remained in the room with the participant during each of the tasks, and instructed them when to start and stop.

2.6. Laboratory procedure
-------------------------

All sessions were run in the afternoon in a light and temperature-controlled laboratory, and participants were tested individually. They were provided with water but were not allowed to eat during testing. Anthropometric measures were obtained and the impedance cardiogram was fitted for continuous assessment of heart rate, HRV and cardiac PEP. Participants were then seated comfortably and fitted with finger cuffs so that blood pressure (BP) could be monitored using the Portapres-2. A venous cannula was inserted into the lower arm for blood sampling, and they were left to rest for 30 min. Cardiovascular measures (BP, heart rate, HRV and cardiac PEP) were recorded for the last 5 min of the baseline rest period, then a saliva sample was obtained and a baseline blood sample was drawn. At this time, participants were asked to rate their subjective feelings of stress on a 7-point Likert scale ranging from 1 = low to 7 = high. Next, the two tasks were administered in a fixed order. Five-minute recordings of cardiovascular activity were made during each of the tasks and cortisol samples and subjective stress ratings were obtained after each task. Following the tasks, a second blood sample was taken and participants rested for a further 45 min. Additional recordings of cardiovascular activity were obtained at 10--15, 25--30 and 40--45 min post-tasks, and a third blood sample was drawn at 45 min. Further measures of subjective stress and cortisol were obtained at 15, 30 and 45 min post-task.

2.7. Statistical analyses
-------------------------

First, we tested whether the tasks used in our study were indeed stressful, by assessing participants' subjective and physiological responses to these tasks using repeated measures analyses of variance (ANOVA). The repeated measures analyses of subjective stress and salivary cortisol involved six trials (baseline, post-Stroop, post-speech, 15, 30 and 45 min post-tasks). Similarly, analyses of heart rate, HRV, cardiac PEP and blood pressure involved six trials (baseline, Stroop, speech, 10--15, 25--30 and 40--45 min post-tasks), while the analyses of plasma cytokines involved three trials (baseline, immediately post-tasks and 45 min post-task). The Greenhouse-Geisser correction of degrees of freedom was applied when sphericity assumptions were violated. The distribution of plasma leptin was skewed so data were square root transformed before analyses. Heart rate variability (RMSSD) data were also skewed and were log transformed, however raw values are presented for comparability with other studies. Post hoc tests were conducted using Tukey\'s least significant difference (LSD) test.

We then investigated the association between adiposity measures and physiological stress responses using a multiple linear regression approach. Three aspects of physiological response were analyzed: baseline levels, stress reactivity (computed as the change in levels between baseline and stress) and stress recovery (computed as the change between baseline and 45 min post-task). Age, smoking status and ethnicity were included in all models as covariates. In regressions involving reactivity and recovery measures, baseline levels of the relevant dependent measure (HR, HRV, etc.) were included as additional covariates in the model. The same regression approach was used to assess the relationship between basal plasma leptin levels and physiological stress responses. This time adiposity measures (BMI, waist circumference and percentage body fat) were also included as covariates, since adiposity is a major determinant of leptin levels and is associated with stress reactivity. Results are presented as standardised regression coefficients (*β*) with standard errors (s.e.). Associations between adiposity (or leptin) measures and reactivity are illustrated by displaying the mean cardiovascular and inflammatory responses of individuals in the lower and higher tertiles of waist circumference or plasma leptin, adjusted for covariates.

3. Results
==========

3.1. Participant characteristics
--------------------------------

Sample characteristics at baseline are presented in [Table 1](#tbl1){ref-type="table"}. Participants were relatively young with a mean age of 21. The majority were White non-smokers. All were normotensive and had glycated haemoglobin (HbA1c) levels in the normal range. Although they were not overweight on average, there were large individual differences in adiposity measures; BMI ranged from 18.4 to 34.0 kg m^−2^, waist circumference ranged from 57.0 to 95.0 cm and percentage body fat ranged from 10.1 to 40.5%. Participants also varied widely in basal plasma leptin levels, ranging from 5.7 to 105.5 ng/ml, with a mean concentration of 35.7 ng/ml, s.d. 22.0. These levels are in the expected physiological range for non-fasting women ([@bib34]).

3.2. Subjective, cardiovascular and neuroendocrine responses to stress
----------------------------------------------------------------------

Participants rated tasks as stressful with a mean score of 4.64 ± 1.1 and 4.42 ± 1.4 during the Stroop and speech task respectively. Subjective stress ratings returned to baseline levels during recovery, falling below baseline at 45 min post-task (*F* (3, 196) = 174.4, *p* \< 0.001). Participants' blood pressure and heart rate increased significantly during the tasks, with mean increases of 13.3 mmHg (*F* (3, 167) = 38.2, *p* \< 0.001) and 10.3 mmHg (*F* (4, 221) = 44.5, *p* \< 0.001) in systolic BP and diastolic BP respectively, and an average rise of 11.5 bpm in heart rate (*F* (2, 149) = 116.3, *p* \< 0.001). At the same time, tasks induced a substantial decrease in participants' HRV and cardiac PEP; HRV decreased by 18.6 ms on average during tasks (*F* (2, 149) = 42.4, *p* \< 0.001), and cardiac PEP decreased by 6.0 ms on average (*F* (2, 131) = 44.7, *p* \< 0.001). There were large individual differences in all cardiovascular responses. For example, changes in heart rate ranged from −1.8 bpm to +30.3 bpm, changes in HRV ranged from −99.4 ms to +4.8 ms, and changes in cardiac PEP ranged from −28.0 ms to +13.0 ms, during tasks. In addition, there was a small but significant (14.5%) rise in salivary cortisol in response to tasks, returning to baseline levels during the rest period (*F* (2, 122) = 9.96, *p* \< 0.001).

3.3. Cytokine stress responses
------------------------------

Tasks induced a small but significant increase in participants' plasma levels of IL-6 (*F* (1, 78) = 21.1, *p* \< 0.001) and leptin (*F* (2, 105) = 26.3, *p* \< 0.001), with maximum levels detected at 45 min post-tasks. Plasma levels of IL-6 increased by 37% on average at 45 min, with responses ranging from −0.45 pg/ml to +1.72 pg/ml. Similarly, plasma leptin levels increased by 14% on average at 45 min, with responses ranging from −6.7 ng/ml to +20.2 ng/ml. IL-1Ra levels were not altered by stress in the sample as a whole. However, there were large individual differences in this response, with changes in plasma IL-1Ra ranging from −148.1 pg/ml to +124.2 pg/ml at 45 min post-task. Plasma concentrations of IL-1Ra and leptin were positively correlated immediately post-stress (*r* = 0.30, *p* = 0.023) and at 45 min post-stress (*r* = 0.32, *p* = 0.020).

3.4. Adiposity and cardiovascular, neuroendocrine and immune measures
---------------------------------------------------------------------

There was a significant relationship between adiposity and diastolic BP. Baseline diastolic BP was associated with BMI, waist circumference and percentage body fat (*β* = 0.29--0.37, s.e. = 0.13--0.14, all *p* \< 0.05), independent of age, ethnicity and smoking status. Similarly, stress-induced increases in diastolic BP at 45 min were related to percentage body fat (*β* = 0.33, s.e. = 0.13, *p* = 0.014) and waist (*β* = 0.26, s.e. = 0.14, *p* = 0.059 ns trend), independent of age, ethnicity, smoking and baseline diastolic BP. There were no associations between adiposity and any other cardiovascular or neuroendocrine measures.

Basal plasma cytokine levels were related to adiposity, independent of age, ethnicity and smoking. Baseline leptin was associated with BMI, waist and percentage body fat (*β* = 0.49--0.62, s.e. = 0.11--0.13, all *p* \< 0.001). Similarly, IL-6 levels were related to BMI and percentage body fat (*β* = 0.28--0.29, s.e. = 0.13--0.14, *p* \< 0.05), and basal plasma IL-1Ra was associated with waist (*β* = 0.41, s.e. = 0.13, *p* = 0.003). There was also a significant relationship between central adiposity and cytokine stress responses. Waist circumference was associated with individual differences in stress-induced increases in plasma leptin immediately post-task (*β* = 0.34, s.e. = 0.15, *p* = 0.022) and stress-induced increases in plasma IL-1Ra at 45 min post-task (*β* = 0.32, s.e. = 0.15, *p* = 0.040), independent of age, ethnicity, smoking and baseline levels of the respective cytokine. The relationship between waist and IL-1Ra responses is illustrated in [Fig. 1](#fig1){ref-type="fig"}, showing mean plasma IL-1Ra concentrations in individuals in the lowest and highest tertiles of waist circumference. People with greater central adiposity had 15% higher IL-1Ra levels at 45 min post-task.

3.5. Basal leptin and cardiovascular, neuroendocrine and immune measures
------------------------------------------------------------------------

Plasma levels of leptin at baseline were significantly related to participants' cardiovascular and inflammatory stress responses, independent of age, smoking, adiposity and baseline measures of the respective dependent variable. Specifically, basal leptin was associated with stress-induced increases in heart rate (*β* = 0.53, s.e. = 0.18, *p* = 0.006) and with decreases in HRV (*β* = −0.44, s.e. = 0.18, *p* = 0.015) and cardiac PEP (*β* = −0.51, s.e. = 0.17, *p* = 0.004) during tasks, independent of covariates. There was also a positive association between basal leptin levels and stress-induced increases in IL-6 at 45 min (*β* = 0.35, s.e. = 0.17, *p* = 0.042). These effects are illustrated in [Fig. 2](#fig2){ref-type="fig"} (A--D). Women in the highest versus lowest tertile of basal leptin had a 2.2-fold greater IL-6 response to stress at 45 min. Similarly, during tasks, women in the highest leptin tertile had 187% greater increases in heart rate, 86% greater reductions in HRV and \>11-fold larger decreases in cardiac PEP. All associations remained significant when controlling for ethnicity (*p* \< 0.05). There was no relationship between basal leptin and measures of diastolic or systolic BP, salivary cortisol or plasma IL-1Ra.

4. Discussion
=============

This study examined the relationship between adiposity, circulating leptin and physiological responses to acute laboratory stress in women. Contrary to our predictions, we found no evidence of an association between adiposity measures and either cardiovascular or neuroendocrine reactivity to stress. However, women with greater total adiposity had impaired post-stress recovery in diastolic BP. In addition, there was a positive relationship between central adiposity and individual differences in cytokine stress responses, such that women with a larger waist circumference had greater stress-induced increases in plasma levels of IL-1Ra and leptin. In line with our hypotheses there was a significant association between participants' basal plasma leptin levels and cardiovascular reactivity to stress, such that women with higher leptin levels displayed greater increases in heart rate and greater decreases in heart rate variability and cardiac PEP during tasks. Interestingly, women with elevated basal leptin also displayed larger stress-induced increases in the inflammatory cytokine IL-6.

The lack of association between adiposity and cardiovascular reactivity is somewhat surprising. However, not all previous studies have found a positive relationship between adiposity and cardiovascular stress reactivity, and the majority of those that did were either carried out in small samples of fewer than 25 participants or in samples that were not representative of the general population and did not adjust for confounding variables ([@bib13; @bib1; @bib43; @bib19]). Similar to our observations, a more recent analysis of 225 middle-aged British civil servants found no association between total or central adiposity and cardiovascular stress reactivity, but found a positive relationship between these measures and impaired post-stress recovery of diastolic blood pressure, independent of traditional risk factors ([@bib38]). Furthermore, the largest study to date carried out in 1647 adults from the West of Scotland Twenty-07 study, found a negative association between adiposity and cardiovascular reactivity such that those with greater BMI and waist--hip ratio as well as those categorised as obese displayed smaller heart rate reactions to stress ([@bib8]). The lack of association between adiposity and cortisol reactivity in our study is difficult to interpret, since the tasks used were only moderately stressful and cortisol responses were very small. More socially evaluative tasks eliciting more robust changes in cortisol may be required to adequately assess this relationship.

The positive association between central adiposity and cytokine stress responses is interesting and adds to the existing literature relating obesity and stress reactivity in humans. White adipose tissue (WAT), in particular visceral WAT, is a major source of leptin and IL-1Ra and the expression of these cytokines is markedly increased in WAT of obese humans and animals ([@bib23; @bib10]). Accordingly, serum levels of leptin and IL-1Ra are elevated approximately 4-fold and 7-fold respectively in obese individuals, where they are positively correlated with BMI and % body fat ([@bib10; @bib30]). Unlike other adipose tissue depots, visceral WAT has a rich blood and nerve supply and a high abundance of glucocorticoid and beta-adrenergic receptors ([@bib4]). Glucocorticoids stimulate leptin gene expression in human and mouse adipocytes in vitro and increase circulating leptin levels in humans ([@bib41; @bib29]). Conversely β-adrenergic agonists inhibit leptin gene expression in adipocytes and lower circulating leptin levels in vivo ([@bib41]) whereas they increase plasma IL-1Ra levels in humans ([@bib37]). The higher expression of cytokines in visceral WAT coupled with a greater density of stress hormone receptors, may explain why we found relationships between cytokine responses and central but not total adiposity ([@bib4]). Together with the existing evidence, our results suggest that adipose tissue may be an important source of stress-responsive cytokines.

Notably, adipose tissue is heterogeneous and contains a stromal vascular cell population including monocytes, as well as adipocytes ([@bib45]). Leptin receptors are expressed on monocytes, and leptin stimulates monocyte production of other cytokines including IL-1Ra and IL-6 by binding to these receptors ([@bib24; @bib17]). It is thus conceivable that basal or stress-induced increases in leptin may drive IL-1Ra and IL-6 responses to stress. This may explain why we found an association between waist circumference and leptin immediately post-stress whereas waist was associated with IL-1Ra levels at 45 min. Supporting a relationship between these two cytokines, plasma concentrations of leptin and IL-1Ra were positively correlated both immediately post-stress and at 45 min. Although adiposity was not related to IL-6 stress responses, women with higher basal leptin levels displayed larger increases in IL-6 following tasks, indicating that elevated leptin levels may drive this inflammatory response.

The observed relationship between basal plasma leptin levels and cardiovascular reactivity to stress is consistent with previous reports in humans and animals supporting a sympatho-activating effect of leptin ([@bib33; @bib12; @bib39; @bib5; @bib16; @bib26]). Although human leptin infusion studies have generated inconsistent results, our findings suggest that leptin may potentiate SNS activity during stress. The effects of leptin on SNS activity are thought to be driven mainly by a central mechanism involving the long form of the leptin receptor (OB-Rb) and melanocortin-3/4 receptors (MC3/4 R) in the hypothalamic arcuate nucleus (ARC). In rodents, microinjection of leptin into the ARC increases arterial pressure and sympathetic outflow to BAT and kidneys, whereas lesions to the ARC blunt the thermogenic SNA response to leptin ([@bib32]). Similarly, central pharmacological blockade or genetic ablation of MC3/4R in rodents abolishes the hypertensive effects of chronic leptin infusion ([@bib11]). In addition, leptin may promote sympathetic activity via direct, non-neural pathways. Leptin receptors have been detected in the heart and endothelium of blood vessels ([@bib3]), and a strong independent association between circulating leptin and heart rate was observed in heart transplant patients with sympathetic denervation, supporting a direct effect of leptin on heart rate conceivably through cardiac leptin receptors ([@bib47]). The sympatho-activating effects of leptin may be more apparent in women. Women are generally more 'adipose' than men, with greater total body fat and significantly higher leptin levels both pre- and post-menopause ([@bib34]). Furthermore, two recent studies found a significant correlation between circulating leptin levels, sympathetic autonomic activity and hypertension in women but not in men ([@bib26; @bib16]), and women display greater cardiovascular reactivity to certain types of acute laboratory stress ([@bib35]).

Heightened or prolonged sympathetic reactivity to acute stress has been shown to predict future hypertension in initially normotensive samples as well as an increased risk of cardiac events in patients with documented cardiovascular disease ([@bib42; @bib15]). Although few studies have examined the prospective relationship between acute cytokine responses and cardiovascular risk, we previously showed that IL-6 responses to laboratory stress were predictive of 3-year elevations in BP in men and women from the Whitehall II cohort ([@bib7]). IL-6 and leptin have a number of pro-atherogenic effects including upregulation of endothelial cell adhesion molecules and promoting smooth muscle cell proliferation and platelet aggregation, and elevated circulating levels of these cytokines are associated with a heightened risk of CVD ([@bib20]). Similarly IL-1Ra has a number of metabolic effects that promote obesity and insulin resistance ([@bib30; @bib23]). Therefore acute cardiovascular and cytokine stress responses may become clinically relevant if repeated on a long-term basis.

This investigation was carried out in a sample of young, predominately white females and results may not generalise to other populations. Cytokines were measured in non-fasting plasma samples, and there is some evidence that ingestion of food with a high carbohydrate or fat content can alter circulating leptin levels in animals ([@bib21]). However, most human studies show only a long-term dietary effect of chronic overfeeding on leptin ([@bib21]). A significant proportion (17.9%) of our participants smoked and smoking is known to affect cardiovascular function and cytokine levels. However, results remained significant when controlling for this factor. Heart rate and HRV are regulated by both parasympathetic vagal withdrawal as well as increases in sympathetic nerve activity, and it would have been useful to include more direct measures of sympathetic activity such as catecholamines. Nevertheless, cardiac PEP is a strong indicator of sympathetic nerve activation ([@bib36]). We also did not control for menstrual cycle. However differences in physiological stress reactivity across the menstrual cycle have been inconsistent ([@bib44]). The multiple statistical analyses performed increases the likelihood of type-1 errors in our results. Lastly, the cross-sectional nature of the study prevents conclusions about the causal direction of associations between adiposity, leptin and stress-reactivity. Since leptin and IL-1Ra play an important role in weight regulation and adipose tissue physiology, stress-induced increases in these cytokines may also impact obesity levels ([@bib41; @bib30]).

Nevertheless, our findings throw some light on the potential mechanisms linking obesity, stress and cardiovascular risk in women. Since visceral WAT is a major source of cytokines, central adiposity may increase cardiovascular risk by facilitating a pro-atherogenic response to stress. Similarly, by driving sympathetic and inflammatory stress responses, leptin may promote the development of future cardiovascular disease. Further experiments are required to confirm our observations in a larger sample including equal numbers of both genders and to test whether there is a prospective association between adiposity or leptin, stress reactivity and cardiovascular risk in humans.
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![Mean plasma concentrations of interleukin-1 receptor antagonist (IL-1Ra) at 45 min post-tasks, in relation to waist circumference. Waist circumference was divided into tertiles and data are presented for individuals with low (\<67 cm) and high (\>70 cm) waist measures. Values are adjusted for age, ethnicity, smoking status and baseline plasma IL-1Ra. Error bars are SEM.](gr1){#fig1}

![Basal circulating leptin and cardiovascular and inflammatory stress responses. Mean stress-induced changes in (A) plasma interleukin-6 (IL-6), (B) heart rate, (C) heart rate variability and (D) cardiac PEP in relation to baseline plasma leptin levels. Leptin levels were skewed and were square root transformed prior to analyses. Baseline plasma leptin was divided into tertiles and data are presented for individuals with low (\<4.8 ng/ml) and high (\>6.4 ng/ml) transformed leptin levels. Values are adjusted for age, smoking status, BMI, waist circumference, % body fat, and baseline levels of the appropriate dependent variable. Error bars are SEM. RMSSD, root mean square of successive R--R interval differences; PEP, pre-ejection period.](gr2){#fig2}

###### 

Participant characteristics (*n* = 67).

                               Mean    s.d.   Range
  ---------------------------- ------- ------ --------------
  Age                          21.3    2.1    18--25
  Smoker (%)                   17.9           
  Ethnicity (% white)          66.7           
  Weight (kg)                  62.0    10.3   47.3--93.8
  Waist (cm)                   70.3    7.9    57.0--95.0
  BMI (kg/m^2^)                23.2    3.1    18.4--34.0
  Body fat (%)                 25.7    5.4    10.1--40.5
  Subjective stress rating     2.0     1.1    1.0--6.0
  Salivary cortisol (nmol/l)   5.5     2.5    1.8--13.7
  Systolic BP (mmHg)           111.5   10.1   90.0--132.0
  Diastolic BP (mmHg)          65.0    8.8    41.3--88.0
  Heart rate (bpm)             72.2    8.7    51.8--91.7
  HRV (ms)                     56.0    29.1   19.4--174.2
  Cardiac PEP (ms)             123.2   8.8    106.8--148.0
  Plasma leptin (ng/ml)        35.7    22.0   5.7--105.5
  Plasma IL-6 (pg/ml)          0.71    0.46   0.27--1.72
  Plasma IL-1Ra (pg/ml)        176.9   73.0   98.7--480.1
  HbA1c                        4.77    0.27   3.9--5.2

*Abbreviations*: BP, blood pressure; HbA1c, glycated haemoglobin; HRV, heart rate variability; PEP, pre-ejection period; IL-6, interleukin-6; IL-1Ra, interleukin-1 receptor antagonist.
